The Saudi Food and Drug Authority encouraged the company to submit a regulatory filing for its recombinant Bacillus Calmette-Guérin, which the company expects to submit within weeks.
Big tech spending on equipment and AI appears to be close to $400 billion over the four quarters. Are there losers outside the free-spending tech titans?
Resource management provider Itron (NASDAQ:ITRI) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 6.7% year on year to $571.7 million. On the other hand, next quarter’s revenue guidance of $570 million was less impressive, coming in 1.8% below analysts’ estimates. Its non-GAAP profit of $2.46 per share was 12.4% above analysts’ consensus estimates.
XRP (CRYPTO: XRP) has fallen roughly 29% over the past month, but some traders say the correction may be nearing exhaustion, setting up a potential relief rally.
The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization.
